Home » Authors » David Liebers, MD

David Liebers, MD

Articles

ARTICLES

Personalized Antidepressant Treatments: Augmentation Options for Different Depression Subtypes

August 25, 2024

Deepti Anbarasan, MD., David Liebers, MD, and Greg Malzberg, MD

In this video, we explore the latest breakthroughs in antidepressant augmentation, showing how personalized medicine can enhance outcomes for patients with various forms of depression. Whether your patient is facing anxious depression, depression with insomnia, or psychotic depression, this video offers evidence-based strategies that incorporate augmenation options such as lithium for depression, esketamine for depression, and quetiapine for depression.

Clinical Update

A Personalized Approach to Antidepressant Augmentation

April 1, 2024

Deepti Anbarasan, MD and David Liebers, MD

Deepti Anbarasan, MD. Associate Professor, Psychiatry and Neurology, New York University, New York, NY.

David Liebers, MD. Psychiatry resident at NYU Langone Department of Psychiatry.

The authors have no financial relationships with companies related to this material.

The best augmentation strategy varies by patient. Learn which features help personalize the plan.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Treating Opioid Use Disorder—A Fact Book (2024)
All the tools you need to assess and treat patients struggling with opioid use disorder.
READ MORE

General Psychiatry
What You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of Trials
Read More

General Psychiatry
PTSD 101: Nine Off-Label Meds
A new medication is knocking on the door for FDA approval in PTSD, and it isn’t MDMA. We cover that, and 8 other off label medications.
Listen now

Sign up to write for us!
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Sign up to write for us!
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

Sign up to write for us!
July 18, 2024
Insights About a Rare Transmissible Form of Alzheimer's Disease
February 9, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners
May 24, 2024

David Liebers, MD

ARTICLES

Personalized Antidepressant Treatments: Augmentation Options for Different Depression Subtypes

A Personalized Approach to Antidepressant Augmentation

Treating Opioid Use Disorder—A Fact Book (2024)

What You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of Trials

PTSD 101: Nine Off-Label Meds

Sign up to write for us!

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Sign up to write for us!

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Sign up to write for us!

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us